Literature DB >> 26152722

Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.

Danielle Beckman1, Luis E Santos1, Tatiana A Americo1, Jose H Ledo2, Fernando G de Mello1, Rafael Linden3.   

Abstract

We sought to examine interactions of the prion protein (PrP(C)) with monoaminergic systems due to: the role of PrP(C) in both Prion and Alzheimer diseases, which include clinical depression among their symptoms, the implication of monoamines in depression, and the hypothesis that PrP(C) serves as a scaffold for signaling systems. To that effect we compared both behavior and monoaminergic markers in wild type (WT) and PrP(C)-null (PrP(-/-)) mice. PrP(-/-) mice performed poorly when compared with WT in forced swimming, tail suspension, and novelty suppressed feeding tests, typical of depressive-like behavior, but not in the control open field nor rotarod motor tests; cyclic AMP responses to stimulation of D1 receptors by dopamine was selectively impaired in PrP(-/-) mice, and responses to serotonin, but not to norepinephrine, also differed between genotypes. Contents of dopamine, tyrosine hydroxylase, and the 5-HT5A serotonin receptor were increased in the cerebral cortex of PrP(-/-), as compared with WT mice. Microscopic colocalization, as well as binding in overlay assays were found of PrP(C) with both the 5HT5A and D1, but not D4 receptors. The data are consistent with the scaffolding of monoaminergic signaling modules by PrP(C), and may help understand the pathogenesis of clinical depression and neurodegenerative disorders.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alzheimer disease; cerebral cortex; depression; monoaminergic neurotransmission; neurodegeneration; prion; prion disease

Mesh:

Substances:

Year:  2015        PMID: 26152722      PMCID: PMC4536454          DOI: 10.1074/jbc.M115.666156

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  107 in total

1.  Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1.

Authors:  Flavio H Beraldo; Camila P Arantes; Tiago G Santos; Nicolle G T Queiroz; Kirk Young; R Jane Rylett; Regina P Markus; Marco A M Prado; Vilma R Martins
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

2.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects.

Authors:  Lin Pei; Shupeng Li; Min Wang; Mustansir Diwan; Hymie Anisman; Paul J Fletcher; José N Nobrega; Fang Liu
Journal:  Nat Med       Date:  2010-11-28       Impact factor: 53.440

Review 4.  Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.

Authors:  Stephanie C Dulawa; Rene Hen
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

5.  Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C).

Authors:  R Roesler; R Walz; J Quevedo; F de-Paris; S M Zanata; E Graner; I Izquierdo; V R Martins; R R Brentani
Journal:  Brain Res Mol Brain Res       Date:  1999-08-25

6.  SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain.

Authors:  David R Thomas; Ellen M Soffin; Claire Roberts; James N C Kew; Raul M de la Flor; Lee A Dawson; Victoria A Fry; Sara A Coggon; Stefania Faedo; Philip D Hayes; David F Corbett; Ceri H Davies; Jim J Hagan
Journal:  Neuropharmacology       Date:  2006-07-17       Impact factor: 5.250

7.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

8.  Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study.

Authors:  J Clinton; C Forsyth; M C Royston; G W Roberts
Journal:  Neuroreport       Date:  1993-01       Impact factor: 1.837

9.  Striatal [123I] FP-CIT SPECT demonstrates dopaminergic deficit in a sporadic case of Creutzfeldt-Jakob disease.

Authors:  M Ragno; M G Scarcella; G Cacchiò; S Capellari; F Di Marzio; P Parchi; L Trojano
Journal:  Acta Neurol Scand       Date:  2008-07-13       Impact factor: 3.209

10.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

View more
  9 in total

1.  Reply to Altered Monoaminergic Systems and Depressive-like Behavior in Congenic Prion Protein Knock-out Mice.

Authors:  Danielle Beckman; Luis E Santos; Tatiana A Americo; Jose H Ledo; Fernando G de Mello; Rafael Linden
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.157

2.  Altered Monoaminergic Systems and Depressive-like Behavior in Congenic Prion Protein Knock-out Mice.

Authors:  Mario Nuvolone; Adriano Aguzzi
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.157

3.  A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease.

Authors:  Danielle Beckman; Rafael Linden
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

4.  Expression of Tyrosine Hydroxylase is Negatively Regulated Via Prion Protein.

Authors:  Marcio Henrique Mello da Luz; Isaias Glezer; Andre Machado Xavier; Marcelo Alberti Paiva da Silva; Jessica Monteiro Volejnik Pino; Thiago Panaro Zamith; Taynara Fernanda Vieira; Bruno Brito Antonio; Hanna Karen Moreira Antunes; Vilma Regina Martins; Kil Sun Lee
Journal:  Neurochem Res       Date:  2016-03-15       Impact factor: 3.996

Review 5.  Prion protein scrapie and the normal cellular prion protein.

Authors:  Caroline J Atkinson; Kai Zhang; Alan L Munn; Adrian Wiegmans; Ming Q Wei
Journal:  Prion       Date:  2016       Impact factor: 3.931

6.  Functions of the cellular prion protein, the end of Moore's law, and Ockham's razor theory.

Authors:  José A del Río; Rosalina Gavín
Journal:  Prion       Date:  2016       Impact factor: 3.931

Review 7.  The Role of the Mammalian Prion Protein in the Control of Sleep.

Authors:  Amber Roguski; Andrew C Gill
Journal:  Pathogens       Date:  2017-11-17

8.  LPS-induced systemic inflammation reveals an immunomodulatory role for the prion protein at the blood-brain interface.

Authors:  Ø Salvesen; M R Reiten; A Espenes; M K Bakkebø; M A Tranulis; C Ersdal
Journal:  J Neuroinflammation       Date:  2017-05-22       Impact factor: 8.322

9.  Comorbidity between Alzheimer's disease and major depression: a behavioural and transcriptomic characterization study in mice.

Authors:  Ana Martín-Sánchez; Janet Piñero; Lara Nonell; Magdalena Arnal; Elena M Ribe; Alejo Nevado-Holgado; Simon Lovestone; Ferran Sanz; Laura I Furlong; Olga Valverde
Journal:  Alzheimers Res Ther       Date:  2021-04-02       Impact factor: 6.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.